Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 17 minutes ago
Back to Filings
FORM 4
AI

Insider Trading - June 16, 2023

Filed June 16, 2023
·
Period ending June 14, 2023
·
0000899243-23-015806

Director Saintil granted 39,446 RSUs ($0) as compensation.

Brief

Merline Saintil, Director at Rocket Lab USA, Inc., acquired 39,446 restricted stock units (RSUs) on June 14, 2023, at $0.00 per share. This represents standard equity compensation under the Non-Employee Director Compensation Policy. The signal is neutral, as it is a routine grant rather than a discretionary purchase or sale.

Detailed Brief

Merline Saintil, a Director of Rocket Lab USA, Inc. (RKLB), was granted 39,446 RSUs on June 14, 2023, pursuant to the company's Amended and Restated Non-Employee Director Compensation Policy. The RSUs vest in full on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, with no exercise price as they represent compensation valued at $0.00 per share. Following the transaction, Saintil owns 439,922 shares directly. The filing does not indicate a Rule 10b5-1 plan, and there are no derivative securities transactions in Table II. This appears to be a standard initial or annual compensation grant for board service, with no evidence of unusual patterns, sales, or timing tied to earnings or announcements.

Key Telemetry

  • 39,446 RSUs granted (~9% increase to 439,922 direct shares)
  • Routine director compensation; vests in 1 year or at next annual meeting
  • Neutral signal: standard equity award, not discretionary buy/sell
  • No 10b5-1 plan; no prior patterns or price context specified

Impact Vector

This routine RSU grant to a director signals standard compensation practices and ongoing board involvement, but provides no strong indication of insider confidence in near-term stock performance. It is neutral overall.

Search
Search across missions, customers, news, and SEC filings